ArticleActa pharmaceutica Sinica. B2024

Transcription factor EHF interacting with coactivator AJUBA aggravates malignancy and acts as a therapeutic target for gastroesophageal adenocarcinoma.

Li Peng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.